The National Biosafety Association-ANBio was created in 1999 by a group of scientists concerned with disseminating information about the advances of modern biotechnology and its control mechanisms, which are fundamental for technological incorporation and simultaneous preservation of our biological diversity. Attentive to the risks arising from laboratory and industrial activities, transport and release to the environment and other activities involving the health and agricultural sectors, target issues of ANBio, biosafety is coming up in Brazil as a multidisciplinary scientific field. Professionals from the most different areas, among others biology, biomedicine, agronomy, food science, pharmacy, chemistry, medicine, nursing, nutrition, architecture and law are brought together in this young discipline.In its two and a half years of existence, ANBio organized about 15 courses on specific biosafety topics such as biotechnology regulation, patent law, biosafety, access to genetic resources; biosafety for health professionals; detection of genetically modified organisms in food products; residues from the health sector; training of biosafety inspectors; biosafety in the pharmaceutical sector; biotechnology for professionals of the media; biosafety for lawyers; biotechnology and biodiversity; bioethics and genetic manipulations; biotechnology and public perception; risk assessment of genetically modified organisms. About 2000 professionals were trained during this period and 350 grants could be awarded by ANBio, allowing cost-free training of public health professionals. ANBio has cooperation agreements with different national and international public and private institutions such as FAPERJ (Research Support Foundation of the State of Rio de Janeiro), CNPq (National Research Council), CAPES (Coordination for post-graduate studies), FINEP (Federal financing agency for studies and projects), FIOCRUZ (Oswaldo Cruz Foundation), UNIVERCIDADE (one of the greatest private universities of Rio de Janeiro), UNEP, ABSA and ISAAA, with the aim to train professionals in the field of biosafety and related sciences. During the same period, ANBio organized two national congresses and two Latin American symposia, which gathered about 1000 professionals from Brazil, Latin America, Europe, the United States, Canada and Asia. The events had great repercussion in the national and international press and caused widespread opinion building impact in the field of modern biotechnology. During the II Brazilian Biosafety Congress (photo 1), ANBio offered a scholarship for a training period at the biggest biosafety research center of the world, the Center for Disease Control and Prevention-CDC, Atlanta, USA, to a Brazilian professional.
Nilo Peçanha avenue, 50 - Groupe 2114 Centro - Rio de Janeiro Brazil 20044-900 Brazil
The National Biosafety Association-ANBio was created in 1999 by a group of scientists concerned with disseminating information about the advances of modern biotechnology and its control mechanisms, wh...
Biological Therapy Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...